Invasive breast carcinoma - IARC

562. Costa MJ, Ames PF, Walls J, Roth LM
(1997). Inhibin immunohistochemistry
applied to ovarian neoplasms: a novel,
effective, diagnostic tool. Hum Pathol 28:
1247-1254.
563. Costa MJ, DeRose PB, Roth LM,
Brescia RJ, Zaloudek CJ, Cohen C (1994).
Immunohistochemical phenotype of ovarian
granulosa cell tumors: absence of
epithelial membrane antigen has diagnostic
value. Hum Pathol 25: 60-66.
564. Costa MJ, Hansen C, Dickerman A,
Scudder SA (1998). Clinicopathologic significance
of transitional cell carcinoma
pattern in nonlocalized ovarian epithelial
tumors (stages 2-4). Am J Clin Pathol 109:
173-180.
565. Costa MJ, McIlnay KR, Trelford J
(1995). Cervical carcinoma with glandular
differentiation: histological evaluation predicts
disease recurrence in clinical stage I
or II patients. Hum Pathol 26: 829-837.
566. Costa MJ, Silverberg SG (1989).
Oncocytic carcinoma of the male breast.
Arch Pathol Lab Med 113: 1396-1399.
567. Costa MJ, Thomas W, Majmudar B,
Hewan-Lowe K (1992). Ovarian myxoma:
ultrastructural and immunohistochemical
findings. Ultrastruct Pathol 16: 429-438.
568. Coukos G, Makrigiannakis A, Chung J,
Randall TC, Rubin SC, Benjamin I (1999).
Complete hydatidiform mole. A disease
with a changing profile. J Reprod Med 44:
698-704.
569. Coyne J.D. (2001). Apocrine ductal
carcinoma in-situ with an unusual morphological
presentation. Histopathology 3 8 :
277-280.
570. Cozen W, Bernstein L, Wang F, Press
MF, Mack TM (1999). The risk of angiosarcoma
following primary breast cancer. Br
J Cancer 81: 532-536.
571. Craig JR, Hart WR (1979). Extragenital
adenomatoid tumor: Evidence for the
mesothelial theory of origin. Cancer 43:
1678-1681.
572. Cramer SF, Roth LM, Ulbright TM,
Mazur MT, Nunez CA, Gersell DJ, Mills SE,
Kraus FT (1987). Evaluation of the reproducibility
of the World Health Organization
classification of common ovarian cancers.
With emphasis on methodology. A r c h
Pathol Lab Med 111: 819-829.
573. Crawford D, Nimmo M, Clement PB,
Thomson T, Benedet JL, Miller D, Gilks CB
(1999). Prognostic factors in Paget's disease
of the vulva: a study of 21 cases.Int J
Gynecol Pathol 18: 351-359.
5 7 4 . Creasman W, Ondicino F,
Maisonneuve P, Benefet J, Shepherd J
(1998). Carcinoma of the corpus uteri:
Annual report on the results of treatment in
gynaecological cancer. J Epidemiol
Biostat 3: 46-47.
575. Creasman WT (1993). Prognostic significance
of hormone receptors in
endometrial cancer. Cancer 71: 1467-1470.
5 7 6 . Creasman WT, Odicino F,
Maisonneuve P, Beller U, Benedet JL,
Heintz AP, Ngan HY, Sideri M, Pecorelli S
(2001). Carcinoma of the corpus uteri. J
Epidemiol Biostat 6: 47-86.
577. Creasman WT, Phillips JL, Menck HR
(1998). The National Cancer Data Base
report on cancer of the vagina. Cancer 83:
1033-1040.
578. Crichlow RW, Galt SW (1990). Male
breast cancer. Surg Clin North Am 70:
1165-1177.
579. Crissman JD, Visscher DW, Kubus J
(1990). Image cytophotometric DNA analy -
sis of atypical hyperplasias and intraductal
carcinomas of the breast. Arch Pathol Lab
Med 114: 1249-1253.
580. Crook T, Brooks LA, Crossland S, Osin
P, Barker KT, Waller J, Philp E, Smith PD,
Yulug I, Peto J, Parker G, Allday MJ,
Crompton MR, Gusterson BA (1998). p53
mutation with frequent novel condons but
not a mutator phenotype in B. Oncogene
17: 1681-1689.
581. Crook T, Crossland S, Crompton MR,
Osin P, Gusterson BA (1997). p53 mutations
in BRCA1-associated familial breast cancer.
Lancet 350: 638-639.
582. Crowe J, Hakes T, Rosen PP, Rosen
PP, Kinne DW, Robbins GF. (1985).
Changing trends in the management of
inflammatory breast cancer: a clinicalpathological
review of 69 patients. Am J
Clin Oncol 8: 21.
583. Crozier MA, Copeland LJ, Silva EG,
Gershenson DM, Stringer CA (1989). Clear
cell carcinoma of the ovary: a study of 59
cases. Gynecol Oncol 35: 199-203.
584. Crum CP (1992). Carcinoma of the
vulva: epidemiology and pathogenesis.
Obstet Gynecol 79: 448-454.
585. Crum CP, Fu YS, Levine RU, Richart
RM, Townsend DE, Fenoglio CM (1982).
Intraepithelial squamous lesions of the
vulva: biologic and histologic criteria for
the distinction of condylomas from vulvar
intraepithelial neoplasia. Am J Obstet
Gynecol 144: 77-83.
586. Crum CP, Ikenberg H, Richart RM,
Gissman L (1984). Human papillomavirus
type 16 and early cervical neoplasia. N
Engl J Med 310: 880-883.
587. Crum CP, Mitao M, Levine RU,
Silverstein S (1985). Cervical papillomaviruses
segregate within morphologically
distinct precancerous lesions. J Virol
54: 675-681.
588. Crum CP, Rogers BH, Andersen W
(1980). Osteosarcoma of the uterus: case
report and review of the literature.
Gynecol Oncol 9: 256-268.
589. Cuatrecasas M, Erill N, Musulen E,
Costa I, Matias-Guiu X, Prat J (1998). K-ras
mutations in nonmucinous ovarian epithelial
tumors: a molecular analysis and clinicopathologic
study of 144 patients. Cancer
82: 1088-1095.
590. Cuatrecasas M, Matias-Guiu X, Prat J
(1996). Synchronous mucinous tumors of
the appendix and the ovary associated
with pseudomyxoma peritonei. A clinicopathologic
study of six cases with comparative
analysis of c-Ki-ras mutations. Am J
Surg Pathol 20: 739-746.
591. Cuatrecasas M, Villanueva A, Matias-
Guiu X, Prat J (1997). K-ras mutations in
mucinous ovarian tumors: a clinicopathologic
and molecular study of 95 cases.
Cancer 79: 1581-1586.
592. Cui J, Antoniou AC, Dite GS, Southey
MC, Venter DJ, Easton DF, Giles GG,
McCredie MR, Hopper JL (2001). After
BRCA1 and BRCA2-what next?
Multifactorial segregation analyses of
three-generation, population-based
Australian families affected by female
breast cancer. Am J Hum Genet 68: 420-
431.
592a. Cui S, Lespinasse P, Cracchiolo B,
Sama J, Kreitzer MS, Heller DS (2001).
Large cell neuroendocrine carcinoma of
the cervix associated with adenocarcinoma
in situ: evidence of a common origin.
Int J Gynecol Pathol 20: 311-312.
593. Cummings MC, Aubele M, Mattis A,
Purdie D, Hutzler P, Hofler H, Werner M
(2000). Increasing chromosome 1 copy
number parallels histological progression
in breast carcinogenesis. Br J Cancer 82:
1204-1210.
594. Cunha TM, Felix A, Cabral I (2001).
Preoperative assessment of deep myometrial
and cervical invasion in endometrial
carcinoma: comparison of magnetic resonance
imaging and gross visual inspection.
Int J Gynecol Cancer 11: 130-136.
595. Cunningham JM, Kim CY, Christensen
ER, Tester DJ, Parc Y, Burgart LJ, Halling
KC, McDonnell SK, Schaid DJ, Walsh VC,
Kubly V, Nelson H, Michels VV, Thibodeau
SN (2001). The frequency of hereditary
defective mismatch repair in a prospective
series of unselected colorectal carcinomas.
Am J Hum Genet 69: 780-790.
596. Cuny M, Kramar A, Courjal F,
Johannsdottir V, Iacopetta B, Fontaine H,
Grenier J, Culine S, Theillet C (2000).
Relating genotype and phenotype in breast
cancer: an analysis of the prognostic significance
of amplification at eight different
genes or loci and of p53 mutations. Cancer
Res 60: 1077-1083.
597. Curry JL, Olejnik JL, Wojcik EM (2001).
Cellular angiofibroma of the vulva with
DNA ploidy analysis. Int J Gynecol Pathol
20: 200-203.
598. Curtin JP, Rubin SC, Hoskins WJ,
Hakes TB, Lewis JL Jr. (1989). Second-look
laparotomy in endodermal sinus tumor: a
report of two patients with normal levels of
alpha-fetoprotein and residual tumor at
reexploration. Obstet Gynecol 73: 893-895.
599. Curtin JP, Saigo P, Slucher B,
Venkatraman ES, Mychalczak B, Hoskins
WJ (1995). Soft-tissue sarcoma of the vagina
and vulva: a clinicopathologic study.
Obstet Gynecol 86: 269-272.
600. Cushing B, Giller R, Ablin A, Cohen L,
Cullen J, Hawkins E, Heifetz SA, Krailo M,
Lauer SJ, Marina N, Rao PV, Rescorla F,
Vinocur CD, Weetman RM, Castleberry RP
(1999). Surgical resection alone is effective
treatment for ovarian immature teratoma
in children and adolescents: a report of the
pediatric oncology group and the children's
cancer group. Am J Obstet Gynecol
181: 353-358.
601. Cutuli B, Borel C, Dhermain F, Magrini
SM, Wasserman TH, Bogart JA, Provencio
M, de Lafontan B, de la RA, Cellai E, Graic
Y, Kerbrat P, Alzieu C, Teissier E, Dilhuydy
JM, Mignotte H, Velten M (2001). Breast
cancer occurred after treatment for
Hodgkin's disease: analysis of 133 cases.
Radiother Oncol 59: 247-255.
602. Cutuli B, Dilhuydy JM, de Lafontan B,
Berlie J, Lacroze M, Lesaunier F, Graic Y,
Tortochaux J, Resbeut M, Lesimple T,
Gamelin E, Campana F, Reme-Saumon M,
Moncho-Bernier V, Cuilliere JC, Marchal
C, De Gislain G, N'Guyen TD, Teissier E,
Velten M (1997). Ductal carcinoma in situ
of the male breast. Analysis of 31 cases.
Eur J Cancer 33: 35-38.
603. Czernobilsky B (1967). Intracystic carcinoma
of the female breast. Surg Gynecol
Obstet 124: 93-98.
604. Czernobilsky B, Gillespie JJ, Roth LM
(1982). Adenosarcoma of the ovary. A lightand
electron-microscopic study with
review of the literature. Diagn Gynecol
Obstet 4: 25-36.
604a. Czernobilsky B, Lancet M (1972).
Broad ligament adenocarcinoma of
Mullerian origin. Obstet Gynecol 40: 238-
242.
605. Czernobilsky B, Moll R, Levy R, Franke
WW (1985). Co-expression of cytokeratin
and vimentin filaments in mesothelial,
granulosa and rete ovarii cells of the
human ovary. Eur J Cell Biol 37: 175-190.
606. d'Ablaing G III, Klatt EC, DiRocco G,
Hibbard LT (1983). Broad ligament serous
tumor of low malignant potential. Int J
Gynecol Pathol 2: 93-99.
607. D'Avanzo B, La Vecchia C (1995). Risk
factors for male breast cancer. Br J
Cancer 71: 1359-1362.
608. D'Orsi CJ, Feldhaus L, Sonnenfeld M
(1983). Unusual lesions of the breast.
Radiol Clin North Am 21: 67-80.
609. Dal Cin P, Timmerman D, Van den
Berghe H, Wanschura S, Kazmierczak B,
Vergote I, Deprest J, Neven P, Moerman P,
Bullerdiek J, Van den Berghe H (1998).
Genomic changes in endometrial polyps
associated with tamoxifen show no evidence
for its action as an external carcinogen.
Cancer Res 58: 2278-2281.
610. Dalal P, Shousha S (1995). Keratin 19 in
paraffin sections of medullary carcinoma
and other benign and malignant breast
lesions. Mod Pathol 8: 413-416.
611. Daling JR, Sherman KJ, Hislop TG,
Maden C, Mandelson MT, Beckmann AM,
Weiss NS (1992). Cigarette smoking and
the risk of anogenital cancer. Am J
Epidemiol 135: 180-189.
612. Dalton LW, Page DL, Dupont WD
(1994). Histologic grading of breast carcinoma.
A reproducibility study. Cancer 73:
2765-2770.
6 1 3 . Daly MB (1992). Ovarian Cancer.
Hematology/oncology clinics of North
America. The epidemiology of ovarian
cancer. WB Saunders: Philadelphia.
614. Damajanov I, Drobnjak P, Grizelj V,
Longhino N (1975). Sclerosing stromal
tumor of the ovary: A hormonal and ultrastructural
analysis. Obstet Gynecol 45: 675-
679.
615. Damiani S, Dina R, Eusebi V (1999).
Eosinophilic and granular cell tumors of
the breast. Semin Diagn Pathol 16: 117-125.
616. Damiani S, Eusebi V, Losi L, D'Adda T,
Rosai J (1998). Oncocytic carcinoma
(malignant oncocytoma) of the breast. Am
J Surg Pathol 22: 221-230.
617. Damiani S, Koerner FC, Dickersin GR,
Cook MG, Eusebi V (1992). Granular cell
tumour of the breast. Virchows Arch A
Pathol Anat Histopathol 420: 219-226.
618. Damiani S, Panarelli M (1996).
Mammary adenohibernoma. H i s t o p a t h o l o g y
28: 554-555.
619. Damiani S, Pasquinelli G, Lamovec J,
Peterse JL, Eusebi V (2000). Acinic cell carcinoma
of the breast: an immunohistochemical
and ultrastructural study.
Virchows Arch 437: 74-81.
620. Damjanov I, Amenta PS, Zarghami F
(1984). Transformation of an AFP-positive
yolk sac carcinoma into an AFP-negative
neoplasm. Evidence for in vivo cloning of
the human parietal yolk sac carcinoma.
Cancer 53: 1902-1907.
621. Dammann R, Li C, Yoon JH, Chin PL,
Bates S, Pfeifer GP (2000). Epigenetic inactivation
of a RAS association domain fami -
ly protein from the lung tumour suppressor
locus 3p21.3. Nat Genet 25: 315-319.
622. Dammann R, Yang G, Pfeifer GP (2001).
Hypermethylation of the cpG island of Ras
association domain family 1A (RASSF1A), a
putative tumor suppressor gene from the
3p21.3 locus, occurs in a large percentage
of human breast cancers. Cancer Res 61:
3105-3109.
References 381